March 2020 FDA Recall Drug by Jubilant Draximage Inc
D-1062-2020 - Failed Stability Specifications

This Class II drug recall was voluntarily initiated by Jubilant Draximage Inc on March 19, 2020 for the product Drug. The FDA reported the reason for recall as failed stability specifications. The product was distributed in Product was distributed throughout the United States. and the recall is currently terminated.

Recall Number: D-1062-2020

Reason for Recall
Failed Stability Specifications
Initiated
03-19-2020
Reported
04-01-2020
Quantity
473 kits of 30 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Jubilant Draximage Inc
Product was distributed throughout the United States.
DRAXIMAGE DTPA (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M PENTETATE INJECTION), 20 mg vial, Rx only, Manufactured for: Jubilant Draximage, Inc., Kirkland, Quebec, Canada, NDC 65174-288-05, 67175-288-30

Batch or Lot Expiration Information

Lot# 8K143, Exp 10/31/2020.